Evidence map›Paper›PMID 19258192›Full record

ArticleBiophysical chemistry2009

Kinetic folding studies of the P22 tailspike beta-helix domain reveal multiple unfolded states.

M L Spatara, C J Roberts, A S Robinson

Abstract read
In one paragraph

Article in Biophysical chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M L SpataraDepartment of Chemical Engineering, University of Delaware, Newark, Delaware 19716, United States.
C J Roberts
A S Robinson

Funding

NOVEL CYSTEINES OF P22 TAILSPIKE PROTEINR01GM060543 · NIGMS · UNIVERSITY OF DELAWARE · PI ROBINSON, ANNE SKAJA · 2000 to 2002
$440k
NIGMS NIH HHS R01 GM060543
6 · The paper itself

Abstract

The beta-helix is an important protein fold in many pathogens, and is a challenging system for folding pathway prediction because it primarily is stabilized by non-local interactions along the primary sequence. A useful experimental model of this fold is a monomeric truncation of P22 tailspike protein, the beta-helix domain (bhx). This report describes a systematic in vitro study of the chemical denaturation and refolding of bhx. Results from equilibrium chemical denaturation experiments were consistent with a two-state folding mechanism, but showed only partial reversibility. Stopped-flow fluorescence studies showed a single unfolding step, but two refolding steps. The slow refolding step could be partly attributed to proline isomerization, based on an increased rate during refolding in the presence of PPIase and an increased relative amplitude of this step with increasing delay time in double-jump refolding experiments observed over delays of 5-100 s. However, double-jump refolding experiments with delay times longer than 100 s along with size exclusion chromatography and dynamic light scattering of refolding samples showed that the overall refolding yield decreased as bhx was unfolded for longer periods of time. Furthermore, the losses resulted from aggregate formation during refolding. This suggests that a change occurs over time in the unfolded or denatured state ensemble that increases the propensity for aggregation upon the shift to more native-favoring conditions. Alternatively aggregate nuclei may be able to form even under high denaturant conditions, and these subsequently grow and consume monomer when placed under native-favoring conditions.

Indexed as

Protein FoldingBacteriophage P22Chromatography, GelFluorescenceGlycoside HydrolasesIsomerismKineticsLightModels, MolecularPeptidylprolyl IsomeraseProlineProtein Structure, TertiaryScattering, RadiationTimeViral Tail ProteinsGlycoside HydrolasesPeptidylprolyl IsomeraseProlinetailspike protein, bacteriophageViral Tail Proteins

Identifiers

PMID19258192
PMCPMC9295601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.